Seeking Alpha

Seeking Alpha Portfolio App for iPad

LATEST ARTICLES

ARTICLES | NEWS | TRANSCRIPTS

Amarin: Limited Downside With Significant Upside
Bio Vantage • AMRN • Fri, Nov 16, 2012, 05:16 ET
The Latest On Amarin - How Will The Investment Pay Off?
Steve Rosenman • AMRN • Tue, Nov 13, 2012, 12:02 ET
Will Amarin Win Investors' Hearts?
Timing Best Buy • AMRN • Tue, Nov 13, 2012, 09:11 ET
Amarin's Dilemma: Sell Vascepa Or Sell Itself?
Bio Vantage • AMRN • Tue, Nov 13, 2012, 04:02 ET
Amarin Releases Q3 Results: What You Need To Know
Brian L. Wilson • AMRN • Mon, Nov 12, 2012, 09:55 ET
Amarin Has Upside Potential With Drug
Efsinvestment • AMRN • Thu, Nov 8, 2012, 18:29 ET
Amarin Stagnates On Frustrating M&A Speculation And (More) Waiting
Brian L. Wilson • GSK, AMRN • Tue, Nov 6, 2012, 21:15 ET
Amarin: Potential For Gains From Possible Buyout
Timing Best Buy • AMRN • Mon, Oct 15, 2012, 14:53 ET
Let's Watch Amarin Get Crushed By Wall Street
Brian L. Wilson • AMRN • Fri, Oct 12, 2012, 09:47 ET
Amarin NCE Decision Delayed Again: What The 8-K Really Tells Us
Red Acre Investments • AMRN • Wed, Oct 10, 2012, 11:13 ET
Amarin: The Basics, Pros, Cons, The Whole Scoop
StockRiters • ABT, GSK, AMRN • Mon, Oct 8, 2012, 14:06 ET
Amarin: Stay Long, Stay Strong
Brian L. Wilson • AMRN • Fri, Oct 5, 2012, 06:05 ET
Conflicting Trading Activity On Amarin As Catalysts Approach
Steve Rosenman • AMRN • Thu, Oct 4, 2012, 10:57 ET
Buy Trinity Biotech: A Safe Biotech Stock Poised For Growth
Qineqt • TMO, TRIB • Wed, Oct 3, 2012, 17:22 ET
Amarin - A Likely Buyout Candidate For 2012 - Focusing On The Bigger Picture
R.S. Analytics • ABT, AZN, GSK • Thu, Sep 27, 2012, 10:33 ET
Amarin: A Good Entry Point Ahead Of Major News Next Month
Red Acre Investments • AMRN • Thu, Sep 27, 2012, 09:11 ET
Amarin: Watch For Big Moves
Efsinvestment • AZN, GSK, PFE • Wed, Sep 19, 2012, 12:43 ET
Amarin Is Still A Buy, Despite NCE Indecision
Qineqt • AZN, GSK, AMRN • Thu, Sep 13, 2012, 03:58 ET
Amarin Confirms NCE Delay - What To Look For Now
Red Acre Investments • AMRN • Tue, Sep 11, 2012, 07:26 ET
Why Vascepa's NCE Status Might Still Be Unresolved This Month
Red Acre Investments • AMRN • Mon, Sep 10, 2012, 07:00 ET
Is Amarin Positioned To Be A Takeover Target?
Bio Vantage • AMRN • Mon, Sep 10, 2012, 04:27 ET
Buying Amarin For Acquisition Potential And Value
Brian L. Wilson • DNDN, GSK, AMRN • Fri, Sep 7, 2012, 13:55 ET
Amarin: A Good Acquisition Target And Strong Buy
Qineqt • ABT, ARNA, GSK • Thu, Aug 23, 2012, 17:04 ET
Amarin: Update On NCE Status And Patent Protection
Efsinvestment • ABT, GSK, AMRN • Mon, Aug 20, 2012, 18:39 ET
Amarin's Fast Approaching NCE Decision - Does It Even Matter?
Red Acre Investments • ARNA, GSK, HZNP • Thu, Aug 16, 2012, 11:02 ET
Elan's Split Will Create 2 Very Different Companies
Stephen Simpson • BIIB, JNJ, PRAN • Tue, Aug 14, 2012, 15:12 ET
Amarin Buyout Rumors Gaining Traction?
Red Acre Investments • GSK, MRK, AMRN • Sat, Aug 11, 2012, 06:49 ET
Amarin's Next Catalysts Could Push Shares Higher
Brian L. Wilson • GSK, AMRN • Thu, Aug 9, 2012, 15:46 ET
Amarin Has Significant Upside Potential
Efsinvestment • AZN, BMY, PFE • Mon, Aug 6, 2012, 15:26 ET
Will GlaxoSmithKline Purchase Amarin?
BiotechWill • AMRN, GSK • Wed, Aug 1, 2012, 12:42 ET
Amarin Path Clearer After FDA Approval
Steve Rosenman • AMRN • Sat, Jul 28, 2012, 05:04 ET
Amarin's AMR101 Offers Catalysts Beyond FDA Approval
Todd Campbell • GSK, AMRN • Fri, Jul 27, 2012, 11:50 ET
If AMR101 Is Approved, Sell Amarin
Rx Stocks • VVUS, AMRN • Tue, Jul 24, 2012, 17:49 ET
How To Trade Amarin After The FDA Decision
Shane Blackmon • ARNA, GSK, PFE • Mon, Jul 23, 2012, 11:27 ET
Amarin Moving Big And Other Healthcare Sector Notes
VFC's Stock House • AGEN, ARNA, BSX • Thu, Jul 19, 2012, 12:11 ET
Amarin Buzzing With Key Date Pending
VFC's Stock House • BMY, GSK, ILMN • Mon, Jul 16, 2012, 07:26 ET
Amarin Valuation Before FDA Action
Bio Vantage • AMRN • Thu, Jul 12, 2012, 07:29 ET
Amarin Is A Hold
Rx Stocks • ABT, ARNA, GSK • Fri, Jul 6, 2012, 07:59 ET
Ireland: The Poster Child Of Growth?
The Angry Bear • EIRL • Thu, Jul 5, 2012, 03:35 ET
Amarin Corporation: A Solid Buyout Play
VFC's Stock House • BMY, GSK, ILMN • Mon, Jul 2, 2012, 08:58 ET
Take Flight With This 6.6% Yielder
Bret Jensen • FLY • Mon, Jul 2, 2012, 00:05 ET
A Diagnostic Update On Trinity Biotech
Wexboy • TRIB • Fri, Jun 22, 2012, 13:06 ET
Amarin Is Headed For A Bullish Run
Longwood Bulls • NEPT, AMRN • Tue, Jun 19, 2012, 03:53 ET
Amarin's Chart And Background Are Indicating A Jump On The Horizon
Spencer Knight • GSK, AMRN • Tue, Jun 12, 2012, 14:03 ET
Amarin Corporation Is On The 'Hot List' With Catalysts Pending
VFC's Stock House • BMY, GSK, ILMN • Mon, Jun 4, 2012, 09:39 ET
Brief Review Of A Few Biotechs
Mina Shaker • ABT, ARNA, OSIR • Mon, May 21, 2012, 22:10 ET
Amarin: May 16 Patent Updates - What Do They Mean?
Ross Klosterman • AMRN • Fri, May 18, 2012, 12:41 ET
Amarin: Most Undervalued Name In Biotech?
Ross Klosterman • AMRN, NEPT, PVNAF.PK • Sun, May 13, 2012, 08:47 ET
Amarin's Fish Oil: Blazing A New Path Against Cardiovascular Disease
Iggy Igette • AMRN, GSK • Wed, May 2, 2012, 16:42 ET
Latest Research Suggests Amarin Value Now Higher As It Awaits FDA Approval
Steve Rosenman • NEPT, AMRN • Fri, Apr 27, 2012, 10:10 ET

First Page
Previous Page
51 - 100 of 261
Next Page
Last Page